SCHEMBL8049644

SCHEMBL8049644

O=c1[nH]c(=O)c2sc3nccnc3c2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MCL1 Q07820 1/20 0.38
TTR P02766 1/20 0.36
CDC7 O00311 1/20 0.36
DBF4 Q9UBU7 1/20 0.36
RPS6KA3 P51812 1/20 0.35
GDA Q9Y2T3 2/20 0.33
ACHE P22303 1/20 0.33
CHEK1 O14757 1/20 0.31
TYMP P19971 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5729400 0.76 KDM4E (0.46) KDM4EALDH1A1HPGDMAPK1HTT
SCHEMBL2300776 0.69 ALDH1A1 (0.34) KDM4EALDH1A1HPGDMAPK1HTT
SCHEMBL2300781 0.67 PIM1 (0.47) KDM4EALDH1A1HPGDMAPK1KMT2A
SCHEMBL5730415 0.64 KDM4E (0.63) KDM4EALDH1A1HPGDMAPK1HTT
SCHEMBL29545868 0.63 KDM4E (0.46) KDM4EALDH1A1MAPK1KMT2AHSD17B10
SCHEMBL932546 0.63 KDM4E (0.46) KDM4EALDH1A1MAPK1KMT2AHSD17B10
SCHEMBL24624032 0.62 ALDH1A1 (0.30) ALDH1A1HSD17B10
SCHEMBL17507345 0.62 PARP1 (0.37) KDM4EALDH1A1KMT2AHSD17B10GDA
Water SCHEMBL6479622 0.62 KDM4E (0.44) KDM4EALDH1A1KMT2AHSD17B10RPS6KA3
Hydrochloric Acid SCHEMBL30431695 0.62 KDM4E (0.44) KDM4EALDH1A1KMT2AHSD17B10RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133275-A ALPHA 1 ADRENORECEPTOR ANTAGONISTS; TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER UROLOGICAL DISEASES E.G., BLADDER OUTLET OBSTRUCTION), NEUROGENIC BLADDER AND GYNECOLOGICAL SYNDROMES, E.G., DYSMENORRHEA; UTERINE MUSCLE RELAXANTS ABBOTT LABORATORIES (US) 2000-10-17 US claimed
WO-1999057122-A1 3-PHENYLPYRROLE ALPHA-1 ADRENERGIC COMPOUNDS ABBOTT LABORATORIES (US) 1999-11-11 WO claimed
US-6133275-A ALPHA 1 ADRENORECEPTOR ANTAGONISTS; TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER UROLOGICAL DISEASES E.G., BLADDER OUTLET OBSTRUCTION), NEUROGENIC BLADDER AND GYNECOLOGICAL SYNDROMES, E.G., DYSMENORRHEA; UTERINE MUSCLE RELAXANTS ABBOTT LABORATORIES (US) 2000-10-17 US disclosed
WO-1999057122-A1 3-PHENYLPYRROLE ALPHA-1 ADRENERGIC COMPOUNDS ABBOTT LABORATORIES (US) 1999-11-11 WO disclosed